{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T02:48:02Z","timestamp":1772851682799,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,29]],"date-time":"2021-12-29T00:00:00Z","timestamp":1640736000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.jfma.2021.12.025","type":"journal-article","created":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T05:24:23Z","timestamp":1641792263000},"page":"1215-1222","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Investigating early progression of Hodgkin lymphoma in a two-center analysis"],"prefix":"10.1016","volume":"121","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4894-9306","authenticated-orcid":false,"given":"Ta-Chuan","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3642-2788","authenticated-orcid":false,"given":"Shan-Chi","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4670-0857","authenticated-orcid":false,"given":"Ren-Ching","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shih-Fan","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9744-0368","authenticated-orcid":false,"given":"Chieh-Lin Jerry","family":"Teng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing-Wei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wan-Ling","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1625-7295","authenticated-orcid":false,"given":"Tai-Chung","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfma.2021.12.025_bib1","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","first-page":"585","year":"2017"},{"key":"10.1016\/j.jfma.2021.12.025_bib2","first-page":"68","article-title":"Hodgkin. On some morbid appearances of the absorbent glands and spleen","volume":"17","year":"1832","journal-title":"Med Chir Trans"},{"issue":"1","key":"10.1016\/j.jfma.2021.12.025_bib3","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13045-019-0799-1","article-title":"Global, regional, and national burden of Hodgkin lymphoma from 1990 to 2017: estimates from the 2017 Global Burden of Disease study","volume":"12","author":"Zhou","year":"2019","journal-title":"J Hematol Oncol"},{"issue":"3","key":"10.1016\/j.jfma.2021.12.025_bib4","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0145-2126(01)00126-6","article-title":"Hodgkin's disease in Asians: incidence patterns and risk factors in population-based data","volume":"26","author":"Glaser","year":"2002","journal-title":"Leuk Res"},{"key":"10.1016\/j.jfma.2021.12.025_bib5","author":"Health Promotion Administration Ministry of Health and Welfare"},{"issue":"2","key":"10.1016\/j.jfma.2021.12.025_bib6","first-page":"116","article-title":"Hodgkin lymphoma: a review and update on recent progress: current Progress in Hodgkin Lymphoma","volume":"68","author":"Shanbhag","year":"2018","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.jfma.2021.12.025_bib7","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.radonc.2015.10.022","article-title":"Association of intensity-modulated radiation therapy on overall survival for patients with Hodgkin lymphoma","volume":"118","author":"Parikh","year":"2016","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"issue":"5","key":"10.1016\/j.jfma.2021.12.025_bib8","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1001\/jamaoncol.2018.5911","article-title":"Association of combined modality therapy vs chemotherapy alone with overall survival in early-stage pediatric Hodgkin lymphoma","volume":"5","author":"Jhawar","year":"2019","journal-title":"JAMA Oncol"},{"issue":"2","key":"10.1016\/j.jfma.2021.12.025_bib9","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/bjh.13943","article-title":"No survival benefit associated with routine surveillance imaging for Hodgkin lymphoma in first remission: a Danish-Swedish population-based observational study","volume":"173","author":"Jakobsen","year":"2016","journal-title":"Br J Haematol"},{"issue":"21","key":"10.1016\/j.jfma.2021.12.025_bib10","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1056\/NEJM199811193392104","article-title":"A prognostic score for advanced Hodgkin's disease. International prognostic factors project on advanced Hodgkin's disease","volume":"339","author":"Hasenclever","year":"1998","journal-title":"N Engl J Med"},{"issue":"24","key":"10.1016\/j.jfma.2021.12.025_bib11","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1200\/JCO.2017.73.8369","article-title":"On the role of interim fluorine-18-labeled fluorodeoxyglucose positron emission tomography in early-stage favorable Hodgkin lymphoma","volume":"35","author":"Hindi\u00e9","year":"2017","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"2","key":"10.1016\/j.jfma.2021.12.025_bib12","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S1470-2045(18)30784-8","article-title":"PET-adapted treatment for newly diagnosed advanced Hodgkin lymphoma (AHL2011): a randomised, multicentre, non-inferiority, phase 3 study","volume":"20","author":"Casasnovas","year":"2019","journal-title":"Lancet Oncol"},{"issue":"25","key":"10.1016\/j.jfma.2021.12.025_bib13","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1056\/NEJMoa1510093","article-title":"Adapted treatment guided by interim PET-CT scan in advanced Hodgkin's lymphoma","volume":"374","author":"Johnson","year":"2016","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.jfma.2021.12.025_bib14","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1200\/JCO.1994.12.3.580","article-title":"Dexa-BEAM in patients with Hodgkin's disease refractory to multidrug chemotherapy regimens: a trial of the German Hodgkin's Disease Study Group","volume":"12","author":"Pfreundschuh","year":"1994","journal-title":"J Clin Oncol"},{"issue":"27","key":"10.1016\/j.jfma.2021.12.025_bib15","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","article-title":"Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification","volume":"32","author":"Cheson","year":"2014","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.jfma.2021.12.025_bib16","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/jjco\/hyz202","article-title":"International comparison of Hodgkin and non-Hodgkin lymphoma incidence","volume":"50","author":"Saito","year":"2020","journal-title":"Jpn J Clin Oncol"},{"issue":"5","key":"10.1016\/j.jfma.2021.12.025_bib17","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1159\/000460819","article-title":"Hodgkin lymphoma outcome: a retrospective study from 3 tertiary centers in Saudi Arabia","volume":"40","author":"Shafi","year":"2017","journal-title":"Oncol Res Treat"},{"issue":"5","key":"10.1016\/j.jfma.2021.12.025_bib18","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/bjh.14734","article-title":"Modification of initial therapy in early and advanced Hodgkin lymphoma, based on interim PET\/CT is beneficial: a prospective multicentre trial of 355 patients","volume":"178","author":"Dann","year":"2017","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.jfma.2021.12.025_bib19","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s12032-011-9902-3","article-title":"Clinical characteristics and prognostic factors in Chinese patients with Hodgkin's lymphoma","volume":"29","author":"Zhu","year":"2012","journal-title":"Med Oncol Northwood Lond Engl"},{"issue":"5","key":"10.1016\/j.jfma.2021.12.025_bib20","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.clml.2017.02.005","article-title":"Clinical features and prognosis analysis of Hodgkin lymphoma: a multicenter retrospective study over a decade of patients in China","volume":"17","author":"Yu","year":"2017","journal-title":"Clin Lymphoma, Myeloma & Leukemia"},{"issue":"6","key":"10.1016\/j.jfma.2021.12.025_bib21","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1002\/pbc.25935","article-title":"ABVD-based therapy for Hodgkin lymphoma in children and adolescents: lessons learnt in a tertiary care oncology center in a developing country","volume":"63","author":"Jain","year":"2016","journal-title":"Pediatr Blood Cancer"},{"issue":"10114","key":"10.1016\/j.jfma.2021.12.025_bib22","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1016\/S0140-6736(17)32134-7","article-title":"PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group","volume":"390","author":"Borchmann","year":"2018","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.jfma.2021.12.025_bib23","first-page":"CD007941","article-title":"Comparison of first-line chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for people with early unfavourable or advanced stage Hodgkin lymphoma","volume":"5","author":"Skoetz","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"10.1016\/j.jfma.2021.12.025_bib24","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1016\/j.jfma.2019.07.003","article-title":"Brentuximab vedotin as a salvage treatment for relapsed and refractory Hodgkin lymphoma patients in Taiwan","volume":"118","author":"Tien","year":"2019","journal-title":"J Formos Med Assoc Taiwan Yi Zhi"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664621005921?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664621005921?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T14:47:05Z","timestamp":1760539625000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929664621005921"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":24,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S0929664621005921"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2021.12.025","relation":{},"ISSN":["0929-6646"],"issn-type":[{"value":"0929-6646","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigating early progression of Hodgkin lymphoma in a two-center analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of the Formosan Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfma.2021.12.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Formosan Medical Association. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}